6.3 Central Venous Catheters & CDC Infection Prevention

Central Venous Catheters & CDC Infection Prevention

Central venous catheters (CVCs) provide immediate vascular access for hemodialysis when an arteriovenous fistula or graft is absent, non-functioning, or maturing. However, catheters carry the highest rates of morbidity, hospitalization, catheter-related bloodstream infection (CRBSI), central venous stenosis, and all-cause mortality of any dialysis access modality. The Centers for Disease Control and Prevention (CDC) and KDOQI guidelines recommend minimizing avoidable catheter exposure while requiring rigorous evidence-based infection prevention bundles.

---

Catheter Classifications & Anatomical Insertion Sites

Hemodialysis catheters differ fundamentally in design, dwell duration, and infection risk:

1. Non-Cuffed Non-Tunneled Catheters (NCNTC)

• Design & Material: Rigid polyurethane dual-lumen catheters inserted percutaneously directly into a central vein without a subcutaneous tunnel.
• Clinical Indications: Emergency hemodialysis for life-threatening hyperkalemia, severe pulmonary edema, acute intoxications, or acute kidney injury (AKI) where renal recovery is anticipated within days.
• Reassess nontunneled catheter necessity frequently and select removal or conversion based on clinical need, infection risk and the care plan rather than one universal dwell limit.

2. Tunneled Cuffed Catheters (TCC / Permacath)

• Design & Material: Flexible silicone or carbothane dual-lumen conduits passed through an 8 to 12 cm subcutaneous tunnel before entering the vein.
• The Dacron Polyester Cuff: Positioned in the subcutaneous tunnel 2 to 3 cm inside the skin exit site. Within 2 to 4 weeks, surrounding fibroblasts invade the porous polyester fibers, producing dense fibrous tissue ingrowth. This cuff serves two critical functions: (1) mechanical anchorage preventing catheter dislodgement, and (2) biological barrier that seals the subcutaneous tract against transluminal bacterial migration from the skin surface.

3. Anatomical Insertion Hierarchy & Venous Sites

• Right Internal Jugular Vein (Preferred): Offers a straight, direct anatomical pathway down the right brachiocephalic vein into the superior vena cava (SVC) and right atrium. Associated with the lowest rates of catheter thrombosis, malposition, and central stenosis.
• Left Internal Jugular Vein (Second-line): Requires the catheter to cross the mediastinum via the left brachiocephalic vein, making two right-angle turns. Results in higher shear stress, reduced blood flow, and greater incidence of central vein stenosis.
• Femoral Vein (Third-line): Traverses the iliac veins into the inferior vena cava. Reserved for patients with exhausted thoracic veins or acute respiratory distress. Associated with high rates of deep venous thrombosis, retroperitoneal hematoma, and gross contamination from groin flora.
• Subclavian Vein: Avoid when feasible in advanced CKD because central venous stenosis can compromise future access. The inserting clinician balances urgent clinical needs and remaining venous options rather than treating the site as impossible under every circumstance.

4. Tip Position and Device Readiness

Right internal jugular placement is generally preferred when appropriate. Tunneled thoracic dialysis catheters often have a tip positioned in the right atrium according to the specific device and insertion technique. Nontunneled and femoral catheters have different placement considerations; a femoral catheter enters the inferior vena cava and its tip is not described as being at the SVC cavoatrial junction. Confirm documented position and permission for use before connection. Flow limitations, infection risk and anticipated duration guide reassessment rather than a universal maximum dwell time for every site.

CDC Core Interventions for Dialysis Bloodstream Infection Prevention

The CDC's Dialysis Bloodstream Infection Prevention Collaborative has demonstrated up to a 50% reduction in bacteremia through standard bundles:

1. Catheter Exit Site Care

• Universal Surgical Masking: Both the patient and the hemodialysis nurse must wear surgical masks (or the patient must turn their head away from the access) during all dressing changes and hub manipulations. This prevents aerosolized nasopharyngeal droplet colonization by Staphylococcus aureus and Staphylococcus epidermidis.
• Personal Protective Equipment: Clean gloves are donned to remove old dressings; hands are sanitized immediately after disposal; sterile gloves are donned for site prep and new dressing application.
• Skin antisepsis: CDC recommends alcohol-based chlorhexidine above 0.5% as first-line therapy. Use a suitable alternative for intolerance. Apply with the product-specified friction and contact time and allow complete air drying; do not replace product instructions with a universal two-minute drying rule.
• Exit-site ointment: CDC identifies povidone-iodine or bacitracin/gramicidin/polymyxin B ointment, subject to catheter compatibility. Availability differs; the facility selects an appropriate compatible product. Mupirocin has resistance and coverage concerns and is not a universal default. Verify the manufacturer’s compatibility before application.
• Dressing: Use sterile dressing and aseptic technique. Replace loose, wet or soiled dressings promptly. Dressing type, change schedule and glove technique follow the approved dialysis protocol and device instructions; a hospital short-term-catheter schedule is not automatically the only dialysis schedule.

2. Catheter Hub Care ("Scrub the Hub")

• Disinfect the exposed catheter hubs every access/disconnection with an appropriate antiseptic and the approved friction/contact and complete-drying procedure. Closed connectors follow their manufacturer instructions.

---

Catheter Lock Protocols & Patient Safety

Because blood stagnates inside catheter lumens between dialysis treatments, an anticoagulant lock solution must be instilled into both arterial and venous lumens to prevent intraluminal thrombus formation.

The lock cycle is: verify the ordered agent and concentration; instill the labeled lumen volume after treatment; then manage the lock before the next connection according to its labeling. A heparin lock is ordinarily aspirated and discarded. Do not assume all modern catheter-lock products have identical removal instructions. Never force a flush against resistance or introduce an unprescribed large heparin bolus.

1. Unfractionated Heparin Locks

• Concentration: Typically 1,000 to 5,000 units/mL.
• Precision Filling: Each catheter lumen has its exact priming volume (e.g., 1.4 mL arterial, 1.5 mL venous) permanently stamped on the plastic clamp or catheter wing. The nurse must fill only the exact specified volume. Overfilling delivers an unintended systemic heparin bolus, causing clinical bleeding; underfilling leaves the distal catheter tip unprotected, promoting intraluminal clotting.

2. Sodium Citrate (4%)

• Citrate locks: Use the ordered formulation and exact volume. Citrate does not cause HIT, but inadvertent systemic exposure can cause hypocalcemia; it is not risk-free.

3. Lock Verification Before Connection

Read the actual lumen volume from the catheter label or records. For a 1.5-mL lumen with a 1,000-unit/mL heparin order, the lock contains 1,500 units. If both lumens have the same volume, the total is 3,000 units, illustrating why inadvertent flushing is consequential. Aspirate a heparin lock according to protocol and account for blood loss. A fixed additional 0.5-mL discard is not a universal rule for every catheter or lock. Inability to aspirate, visible damage or leakage requires assessment before use. Follow the specific thrombolytic or antimicrobial-lock instructions when those agents are ordered.

Catheter Dysfunction & Flow Restoration

Catheter dysfunction means inability to deliver the required treatment despite appropriate management; older 300-mL/min definitions and pressure cutoffs are not universal for every prescribed treatment.

Etiologies & Fibrin Sheath Pathology

• Intraluminal Thrombus: Clotted blood within the dead space of the lumen.
• Catheter Kinking: Mechanical twisting within the subcutaneous tunnel or acute angle at the venotomy site.
• Fibrin Sheath Formation: Within days to weeks of insertion, smooth muscle cells, endothelial cells, and thrombus form a circumferential fibrocellular sleeve encasing the outer surface of the catheter. This sheath acts as a one-way flap valve: positive pressure during fluid infusion pushes the sheath away from side holes, allowing easy infusion, but negative suction during aspiration pulls the sheath tightly over the ports, completely blocking blood withdrawal.

Nursing Troubleshooting & Interventions

1. Positioning Maneuvers: Reposition the patient, have them cough, take deep breaths, or roll onto their side to free a catheter tip abutting the vena caval or atrial wall.
2. Avoid forceful flushing. Use the catheter-specified syringe and procedure and obtain evaluation of resistance or inability to aspirate.
3. Ordered thrombolytic treatment follows the actual agent’s label, catheter volume and dwell procedure; reassess before use and never force a resistant lumen.
4. Line reversal may temporarily improve flow but can increase recirculation. Use only under the approved plan, record it and arrange dysfunction assessment; the percentage effect is not universal.

Sources checked 2026-10-10: CDC dialysis BSI prevention